financetom
Business
financetom
/
Business
/
ASPI Stock Soars Amid Isotope Production Milestones, Capacity Boost: What Investors Need To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ASPI Stock Soars Amid Isotope Production Milestones, Capacity Boost: What Investors Need To Know
Jul 18, 2025 11:12 AM

ASP Isotopes Inc ( ASPI ) shares are surging Friday morning as the stock trends across social media. The company on Thursday provided several positive updates on its isotope enrichment facilities in Pretoria, South Africa. Here’s what investors need to know.

What To Know: The advanced materials company announced it began commercial production of Silicon-28 in late March 2025, successfully enriching large quantities to 99%. ASP Isotopes ( ASPI ) anticipates shipping finished product, enriched to at least 99.995%, to customers in August 2025.

The company also significantly increased its annual capacity guidance for Silicon-28 to over 80 kilograms, up from 50 kilograms, following a $4 million investment.

Ytterbium-176 commercial production commenced in April 2025, with intermediate product reaching 92.4% enrichment. The company expects to ship commercial samples in August 2025 and transition to a semi-continuous processing method, targeting 1 kilogram per year.

ASP Isotopes ( ASPI ) also secured initial permits for importing equipment to enrich Nickel-64, Gadolinium-160, and Zinc-68, and is accelerating plans for additional enrichment facilities. Furthermore, the company is now enriching Carbon-12 to 99.99% in its existing Carbon-14 plant due to significant demand, with commercial shipments expected in August.

Other corporate updates include the anticipated spin-out of its subsidiary Quantum Leap Enrichment in October 2025 and the expected closure of the Renergen acquisition in the third-quarter of 2025.

Benzinga Edge Rankings: Benzinga Edge, a tool designed to help investors identify strong and weak stocks, provides specific rankings for ASPI. The company shows exceptionally strong Momentum with a score of 97.77, indicating that the stock has been experiencing significant upward price trends.

In contrast, its Value ranking is quite low at 4.12, suggesting that, based on various valuation metrics, the stock may not be considered a bargain.

Price Action: According to data from Benzinga Pro, ASPI shares are trading higher by 6.4% to $10.27 Friday morning, The stock has a 52-week high of $10.66 and a 52-week low of $1.86.

Read Also: Trump Wants To Make Nuclear Great Again–Like It’s 1955

How To Buy ASPI Stock

By now you're likely curious about how to participate in the market for ASP Isotopes ( ASPI ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

In the case of ASP Isotopes ( ASPI ), which is trading at $10.21 as of publishing time, $100 would buy you 9.79 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Google Parent Alphabet Agrees To Buy Cyber Security Group Wiz For $32 Billion - FT
BRIEF-Google Parent Alphabet Agrees To Buy Cyber Security Group Wiz For $32 Billion - FT
Mar 18, 2025
March 18 (Reuters) - * GOOGLE PARENT ALPHABET AGREES TO BUY CYBER SECURITY GROUP WIZ FOR $32 BILLION - FT * ALPHABET-WIZ DEAL WILL BE ANNOUNCED ON TUESDAY MORNING - FT Source text: https://tinyurl.com/3sfyfwz2 Further company coverage: ...
Russia's sovereign wealth fund is eyeing rare earth projects with US companies, CEO says
Russia's sovereign wealth fund is eyeing rare earth projects with US companies, CEO says
Mar 18, 2025
MOSCOW (Reuters) - Russia's sovereign wealth fund is eyeing the development of rare earth deposits in the country and wants to partner with U.S. companies, Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said on Tuesday. Dmitriev, who has also been appointed President Vladimir Putin's envoy on international economic cooperation, was part of Russia's negotiating team at talks...
Westinghouse Air Brake Technologies to Acquire Dellner Couplers for $960 Million
Westinghouse Air Brake Technologies to Acquire Dellner Couplers for $960 Million
Mar 18, 2025
07:47 AM EDT, 03/18/2025 (MT Newswires) -- Westinghouse Air Brake Technologies ( WAB ) said Tuesday it signed a definitive agreement to acquire train connection systems provider Dellner Couplers for $960 million in cash, financed through cash on hand and short-term debt. The acquisition is expected to contribute to an increase in adjusted earnings before interest and taxes margins, adjusted...
Telix Pharmaceuticals' Illuccix Approved in Brazil for Prostate Cancer Imaging; Forms Joint Venture With R2PHARMA
Telix Pharmaceuticals' Illuccix Approved in Brazil for Prostate Cancer Imaging; Forms Joint Venture With R2PHARMA
Mar 18, 2025
07:46 AM EDT, 03/18/2025 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) said late Monday that the Brazilian Health Regulatory Agency has approved the company's prostate cancer imaging agent, Illuccix. The company said the approval was granted to Telix's partner, R2PHARMA, and a subsidiary of Grupo GSH, which has been given an exclusive license to manufacture, distribute and market Illuccix...
Copyright 2023-2026 - www.financetom.com All Rights Reserved